She was born in Islamabad Pakistan. She received her Bachelor’s degree in Physics with majors in Nanotechnology from International Islamic University (IIU) Islamabad, Pakistan. After that she did her Masters in Materials and Surface Engineering from National University of Sciences and Technology (NUST), Islamabad, Pakistan. During her Master’s, she worked on improving the efficiency of ZnO/ Graphene nanocomposite based hybrid photovoltaic devices. she has also worked as a Research assistant at NUST and worked on different projects like dielectric spectroscopy of Graphene/ Thermoplastic Polyurethane nanocomposites, Liquid Crystal based Biosensors and Synthesis of ZnO nanofibers via Electrospinning technique. Also went to Tallinn University of Technology (TTU), Estonia as part of a research internship in 2017. During her stay at Estonia she worked on ZnO nanorods synthesis via Chemical Spray Pyrolysis (CSP) technique and to make their composite with Graphene via the same technique for photocatalytic applications. Her research interests includes Nanotechnology, Graphene based Biosensors, Nanocomposites, Electrochemistry, Surface functionalization, Photovoltaic devices.
Ms. Jagriti Sethi was born in New Delhi, India in 1993. She received her Bachelor's and Master's in Nanotechnology (2016) from Amity Institute Of Nanotechnology, Amity University, India. For her undergraduate research, she worked in Centeral Scientific Instruments Organization, Chandigrah, India on 'Hydroxyapaetite- Chitosan Nanocomposite' in 2015 and in University Of Paris, France on 'Nanosheets' in 2016 as part of her postgraduate research. Her main objective is to do something for the betterment of the people which has inspired her take up a career in research and technology. Her research interests include Biosensor technology, Drug delivery systems and Nanomedicines.
Mr. Michiel Van Bulck was born in Antwerp, Belgium in 1991. He received a Bachelor’s and Master’s of Science in Biomedical Sciences in 2016 from the ‘Vrije Universiteit Brussel (VUB)’, Brussels, Belgium. His main field of interest is neurodegeneration and regeneration. During his master studies he gained multidisciplinary national research experience at Sonic Healthcare Benelux (Belgium) and Cryo-Save Labs (The Cell Factory, R&D Unit (Belgium)) as well as international research experience at Lund University (Biomedical Center, Experimental Dementia Research Unit (Sweden)). These research internships with an emphasis on neurodegenerative diseases, stem cells, biomaterials, toxicology and high-throughput techniques shape his further scientific career.
Mr. Aronne Bolelli was born in Bologna, Italy on 1990. He received a Bachelor’s and Master’s in Molecular Biotechnology in 2016 from Alma Mater Studiorum A.D. 1088, University of Bologna, Italy. For his undergraduate research, he worked in department of Specialist, Diagnostics and Sperimental Medicine (DIMES),Bologna, Italy on immunology and cellular senescence in aging in 2013 and in Cancer Epigenetics and Biology Program (PEBC-IDIBELL),Barcelona, Spain on epigenetic and genetic mechanism involved in cancer diseases in 2016. During his college career he gained research experience on recombinant DNA technology, gene silencing, epigenetics, steam cells and the most common techniques of cell culture and molecular biology. His fields of interest are particularly focused on study designs and analyses for biomarker research, telomerase activity, gene therapy and telomere shortening associated with human degenerative diseases and aging.
Ms. Marina Blūma (née Selivanova) was born and grew up in St. Petersburg, Russia. Prior to getting her Master's degree in Interdisciplinary Neuroscience (2015) at the Goethe University in Frankfurt am Main, she has earned a Diploma with a major in Clinical Psychology at the St. Petersburg State University (2011). In her undergraduate and postgraduate research activities, she addressed the neurobiological basis of mental disorders with behavioural and neuroimaging methods. She believes that the development of new strategies of early biomarker-based diagnostics, would significantly postpone and mitigate the Alzheimer's disease manifestation, and reduce associated emotional, psychological and financial burden for the affected individuals and their relatives.
Ms. Soraya Moradi Bachiller was born in Cáceres (Spain) in 1993. She received her Bachelor’s degree in Biochemistry in 2015 from the University of Castilla-La Mancha (Spain) when she discovered her interest in neurodegeneration. She started postgraduate studies in two different domains, Neuroscience (in 2016 from the University of Salamanca, Spain) and Biology of Aging (in 2017 from the University of Versailles, France). In her postgraduate research, she was interested in two of the most complex biological systems, nervous and cardiac systems. But it was during her graduate research, in 2015, where she found out her passion for the application of systems biology to the study of neurodegenerative diseases, based on the principle that genes and proteins do not act individually, but through complex interactions.
She was born in Cairo, Egypt in 1985. She received her Bachelor of Medicine & Surgery (M.B.B.CH), Ain Shams University, Egypt in 2008 and her Master’s degree in Diagnostic and Interventional Radiology from Ain Shams University, Egypt in 2012. Then she started training as a neuroradiology fellow in Misr radiology center (MRC) , where she acquired a considerable experience in advanced MRI Techniques & applications in neuroimaging ranging from MR-diffusion, Perfusion , Spectroscopy , Diffusion tensor imaging (DTI ) both in brain & spinal cord , taskbased functional MRI & finally Resting state functional MRI. Implementing both structural and functional MRI techniques as reliable tools within the diagnostic battery of preclinical stages of Dementia and Mild cognitive impairment is a kind of dream and an extension to the research projects she was involved in in Egypt.
Ms. Ourania Tzara was born in Athens, Greece in 1987. She is a Biologist and received her Master’s degree in “Applications of Biology in Medicine” from the University of Athens in Greece. Through her postgraduate studies and afterwards, while working at the Biomedical Research Foundation of the Academy of Athens, Greece, she focused on research in the field of Neuroimmunology and in particular on research projects regarding inflammatory molecules and receptors, along with their role in pathogenesis of Alzheimer’s Disease in vivo. Her goal is to contribute in research regarding diagnosis and treatment of
neurodegenerative diseases on the highest scientific level possible and thereby advance medical research.
Arianna Toppi was born and grew up in the province of Siena (Tuscany, Italy). She received her undergraduate and postgraduate education at the University of Florence. She got the Bachelor degree in Chemical Science in 2014 and during the thesis period she was enrolled in the laboratory of Dr. Lucia Becucci, working on the construction of biomimetic membranes on a Dropping Mercury Electrode. The project aimed at investigating the interactions of lipid environments with a peptide structure called CT35 and its tetraglucosylated form, previously developed as a synthetic antigenic probe recognizing specific autoantibodies in Rett syndrome patients’ serum. In 2016, She spent seven months abroad at the CICbiomaGUNE in San Sebastian (Spain), where she worked on a project under the supervision of Prof. Juan C. Mareque-Rivas, whose aim was the development of a drug delivery system, i.e. porous microparticles made of PLGA (Poly Lactic-co-Glycolic Acid) for the transport of anticancer drugs and the assessment of their cytotoxicity through in vitro assays. In October 2016 I obtained my Master degree in Supramolecular and Inorganic Chemistry. Over the years, She developed a strong interest in the healthcare field and her objective is to give a contribution to the improvement of health and life quality of people. On the 1st of July 2017 She joined the Fluidic Array Systems and Technology (FAST) Group of Prof. Martin Dufva as PhD student at the Department of Micro- and Nanotechnology of the Technical University of Denmark, working on the multiplexing of digital analysis of serum samples for Alzheimer’s disease diagnostics, using microRNA and proteins as target biomarkers.
He was born (1989) and raised in Enugu State, Nigeria. He received his Bachelor’s and Master’s Degrees in Electronic Engineering from the University of Nigeria (UNN) in 2013 and 2017, respectively. He specialized in Computer Engineering. He had a strong passion for Medical Electronics. He loved seeing
people stay healthy and productive. His master’s thesis was on the development of biometric-assisted unique patient identifier system. After his graduation from the undergrad and completion of the National Youth Service, he worked as a graduate assistant at the University of Nigeria. His research
interests border on intelligent systems and medical electronics. His goal is to apply his findings and skills to developing systems that will aid and promote healthy living.
Ms Jessica Janson was born in Gotha, Germany on December 1 st in 1987. She has a degree as graduate engineer in Biomedical Technology from the University of Applied Science Lübeck (2012). Her Masters degree in Medical Biotechnology was awarded by the University of Rostock (2015). In her diploma project she adapted commercial microarray technology for use in micro gravity with EADS Astrium (Immenstaad at Lake Constance), which resulted in two patents. Her second graduate project was developing element and structural analysis methods for Cholesterol and oxalic acid with Celisca (Rostock). She has a passion for combining technology and human biology and found in this project the means to do both.
Mr. Bin Gao was born and grew up in Hebei Province, China. He received his Bachelor’s Degrees in Management from the Tianjin University, China in 2012 and Master of Science Degree in Management from Purdue University (USA) in 2013. He also obtained his Master’s Degree in Finance from Tianjin University, China in 2015. After his graduation, he worked as a Research Analyst Futures First Investment Consulting Co. Ltd., China. He has been awarded as the designation of Chartered Financial Analysts by the CFA Institute (USA). His current research interests include business with management, finance, and business model innovation. His goal is to apply his knowledge and skills to develop an innovative business model that will commercialize the technology development of the early diagnosis of Alzheimer’s disease in order to improve the overall quality of life and add value to society.